BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2455354)

  • 1. Disease-modifying agents in rheumatoid arthritis.
    Lipsky PE
    Ryumachi; 1987 Dec; 27(6):409-12. PubMed ID: 2455354
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
    Kovarsky J
    Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276
    [No Abstract]   [Full Text] [Related]  

  • 4. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
    Harth M; Keown PA; Orange J
    J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of antiarthritic drugs.
    Boyce E
    Clin Podiatr Med Surg; 1992 Apr; 9(2):327-48. PubMed ID: 1350233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-modifying drugs for progressive rheumatoid arthritis.
    Bunch TW; O'Duffy JD
    Mayo Clin Proc; 1980 Mar; 55(3):161-79. PubMed ID: 6766523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs in the management of rheumatoid arthritis.
    Bresnihan B
    Ir Med J; 1982 Jan; 75(1):7-9. PubMed ID: 6806208
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug treatment of rheumatoid arthritis.
    Brooks PM
    Aust N Z J Med; 1978; 8 Suppl 1():101-5. PubMed ID: 103522
    [No Abstract]   [Full Text] [Related]  

  • 9. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
    Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of slow-acting antirheumatic drugs on blast formation of normal lymphocytes].
    Hamai T; Negishi M; Takahashi T
    Ryumachi; 1983 Aug; 23(4):193-201. PubMed ID: 6420896
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of rheumatoid arthritis with gold.
    Liang GC
    Wis Med J; 1978 Aug; 77(8):S71-2. PubMed ID: 99882
    [No Abstract]   [Full Text] [Related]  

  • 12. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
    Batlle Gualda E
    Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
    [No Abstract]   [Full Text] [Related]  

  • 13. Organic gold compounds in the treatment of rheumatoid arthritis.
    Rooney TW; Furst DE
    Iowa Med; 1985 Feb; 75(2):74-7. PubMed ID: 3918952
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of anti-arthritic gold compounds on mycoplasma and leishmania.
    Berkoff CE; Actor P; Sutton BM; Walz DT; Klinikowski N
    Arzneimittelforschung; 1974 Dec; 24(12):1988-90. PubMed ID: 4217631
    [No Abstract]   [Full Text] [Related]  

  • 15. Rheumatoid arthritis therapy: the slow-acting agents.
    Hardin JG
    Hosp Pract (Off Ed); 1989 Jun; 24(6):163-8, 170, 173-8. PubMed ID: 2566617
    [No Abstract]   [Full Text] [Related]  

  • 16. Is the mechanism of action during treatment of rheumatoid arthritis with penicillamine and gold thiomalate the same?
    Jellum E; Aaseth J; Munthe E
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):136-9. PubMed ID: 122761
    [No Abstract]   [Full Text] [Related]  

  • 17. Planning a treatment program for rheumatoid arthritis.
    Mayne JG
    Geriatrics; 1973 Jun; 28(6):92-7. PubMed ID: 4196789
    [No Abstract]   [Full Text] [Related]  

  • 18. "Disease-modifying" drugs in rheumatoid arthritis.
    Drug Ther Bull; 1985 Dec; 23(26):101-4. PubMed ID: 2866082
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possible mechanism of action of drugs in the basic therapy of rheumatoid arthritis: effect on platelet aggregation].
    Fioravanti A; Lolatte V; Giordano N; Frati E; Castagna ML; Morozzi G; Lalumera M; Marcolongo R
    Boll Soc Ital Biol Sper; 1984 May; 60(5):1051-6. PubMed ID: 6432005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro effects of gold salts on lymphocyte transformation responses and antibody dependent cell-mediated cytotoxicity.
    Davis P; Percy JS; Russell AS
    J Rheumatol; 1979; 6(5):527-33. PubMed ID: 118255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.